Mechanism of Ginseng-Mulberry Treating Osteoporosis Based on Pharmacodynamics <i>in Vitro</i> Combined with Network Pharmacology and Molecular Docking

LIU Ling; LI Chunnan; LAN Meng; WU Mengya; ZHANG Hui; BIAN Xuefeng

doi:10.13386/j.issn1002-0306.2021010155

Volume 42 Issue 20

Oct. 2021

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2021 > 42(20): 1-13. > DOI: 10.13386/j.issn1002-0306.2021010155

LIU Ling, LI Chunnan, LAN Meng, et al. Mechanism of Ginseng-Mulberry Treating Osteoporosis Based on Pharmacodynamics in Vitro Combined with Network Pharmacology and Molecular Docking[J]. Science and Technology of Food Industry, 2021, 42(20): 1−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021010155.

Citation:

PDF (3155 KB)

Mechanism of Ginseng-Mulberry Treating Osteoporosis Based on Pharmacodynamics in Vitro Combined with Network Pharmacology and Molecular Docking

1.
Jilin Ginseng Research Institute, Changchun University of Traditional Chinese Medicine, Changchun 130117, China
2.
Jilin Province Northeast Asia Biology Science and Technology Co., Ltd., Changchun 130117, China

More Information

Received Date: January 19, 2021
Available Online: August 16, 2021

Graphical Abstract

Abstract

Abstract

Objective: To explore the molecular mechanism of water extract and alcohol extract of ginseng and mulberry in treating osteoporosis by means of network pharmacology. Methods: The effects of water extract and alcohol extract of ginseng and mulberry on proliferation rate and testosterone secretion of mouse leydig cells (TM3), and the effects of water extract and alcohol extract of medicine pair on proliferation rate and alkaline phosphatase (ALP) activity of osteoblasts (MC3T3-E1) were observed. Collect chemical components, components and disease-related targets of ginseng and mulberry respectively through traditional Chinese medicine composition database TCMSP, GeneCards and OMIM. After the intersection of that, using STRING database to analyze protein interaction among key targets, and using DAVID database to analyze biological functions and pathways. The related results were mapped and analyzed by Cytoscape 3.7.0. Autodock software was used to perform molecular docking between potential pharmacodynamic substances and key targets. Results: Compared with the model control group, the cell proliferation rate of TM3 administration group was significantly higher than that of single drug, and it was concentration-dependent. The highest proliferation rate was found at the concentration of 200 μg/mL, which was 97.31% and 91.67% (P<0.01), and testosterone secretion was 3.48 and 3.06 ng/mL. Compared with the blank control group, the cell proliferation rate of MC3T3-E1 administration group increased significantly. The proliferation rate of cells at the concentration of 200 μg/mL was the highest in the group of water extract administration, and the proliferation rate was 155%. The highest cell proliferation rate was 142.8% at 100 μg/mL of alcohol extract. The results of ALP analysis showed that the drug had obvious increasing effect on both water extract group and alcohol extract group. In this study, 28 active components and 69 key targets were collected, and 257 biological process, 34 cell compound and 62 molecular function were collected by GO function enrichment. 109 pathways were collected from KEGG pathway enrichment. The results of molecular docking showed that the energy of potential pharmacodynamic substances docking with key targets IL6, ALB, MAPK8 and CASP3 was lower than 0 kcal/mol. Conclusion: This paper revealed the potential pharmacodynamic substances and targets of ginseng-mulberry medicine in the treatment of osteoporosis, which would lay a foundation for the development and follow-up research of ginseng-mulberry medicine.
- ginseng,
- mulberry,
- osteoporosis,
- cell experiment,
- network pharmacology,
- molecular docking

FullText(HTML)

References (38)

References

[1]	Alejandro P, Constantinescu F. A review of osteoporosis in the older adult: An update[J]. Rheumatic Disease Clinics of North America,2018,44(3):437−451. doi: 10.1016/j.rdc.2018.03.004
[2]	Jergas M. Radiology of osteoporosis[J]. Canadian Association of Radiologists Journal,2016,67(1):28−40. doi: 10.1016/j.carj.2015.02.002
[3]	申浩, 赵海燕, 魏戌, 等. 骨代谢标志物在骨质疏松症中医药诊疗中的应用研究进展[J]. 中国骨质疏松杂志,2017,23(10):1386−1390. [Shen Hao, Zhao Hai-yan, Wei Xu, et al. Application of bone metabolic markers in the diagnosis and treatment of osteoporosis in traditional Chinese medicine[J]. Chinese Journal of Osteoporosis,2017,23(10):1386−1390. doi: 10.3969/j.issn.1006-7108.2017.10.025
[4]	葛继荣, 郑洪新, 万小明, 等. 中医药防治原发性骨质疏松症专家共识(2015)[J]. 中国骨质疏松杂志,2015,21(9):1023−1028. [Ge Ji-rong, Zheng Hong-xin, Wan Xiao-ming, et al. Expert consensus on the prevention and treatment for primary osteoporosis witn traditional Chinese medicine(2015)[J]. Chinese Journal of Osteoporosis,2015,21(9):1023−1028. doi: 10.3969/j.issn.1006-7108.2015.09.001
[5]	尚奇, 任辉, 沈耿杨, 等. 基于肾主骨生髓理论探讨老年性骨质疏松症的中医治疗[J]. 中医杂志,2017,58(16):1433−1435. [Shang Qi, Ren Hui, Shen Geng-yang, et al. Discussion on TCM treatment of senile osteoporosis based on the theory of kidney governing bone and marrow[J]. Journal of Traditional Chinese Medicine,2017,58(16):1433−1435.
[6]	Hopkins Andrew L. Network pharmacology: The next paradigm in drug discovery[J]. Nature Chemical Biology,2008,4(11):682−690. doi: 10.1038/nchembio.118
[7]	Zhang R, Zhu X, Bai H, et al. Network pharmacology databases for traditional Chinese medicine: Review and assessment[J]. Front Pharmacol,2019,10:123. doi: 10.3389/fphar.2019.00123
[8]	Tian G, Wu C, Li J, et al. Network pharmacology based investigation into the effect and mechanism of modified Sijunzi decoction against the subtypes of chronic atrophic gastritis[J]. Pharmacol Res,2019,144:158−166. doi: 10.1016/j.phrs.2019.04.012
[9]	Wang W, Liu T, Yang L, et al. Study on the multitargets mechanism of triphala on cardio-cerebral vascular diseases based on network pharmacology[J]. Biomed Pharmacother,2019,116:108994. doi: 10.1016/j.biopha.2019.108994
[10]	Ru J, Li P, Wang J, et al. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13. doi: 10.1186/1758-2946-6-13
[11]	薛潇春, 胡晋红. 网络药理学的研究方法与应用进展[J]. 药学实践杂志,2015,33(5):401−405. [Xue Xiao-chun, Hu Jin-hong. Research methods and application in network pharmacology[J]. Journal of Pharmaceutical Practice,2015,33(5):401−405. doi: 10.3969/j.issn.1006-0111.2015.05.005
[12]	Huang D W, Sherman B T, Lempicki R A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists[J]. Nucleic Acids Res,2009,37(1):1−13. doi: 10.1093/nar/gkn923
[13]	Trott O, Olson A J. Auto dock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading[J]. J Comput Chem,2010,31(2):455−461.
[14]	张玉领, 陈培, 刘家秀, 等. 中国汉族人群IL-6与骨质疏松相关性的Meta分析[J]. 中国老年学杂志,2014,34(6):1495−1496. [Zhang Yu-ling, Chen Pei, Liu Jia-xiu, et al. Meta-analysis of the correlation between IL-6 and osteoporosis in Chinese Han population[J]. Chinese Journal of Gerontology,2014,34(6):1495−1496.
[15]	Qing Wu. IL-6 enhances osteocyte-mediated osteoclasto genesis by promoting JAK2 and RANKL activity in vitro[J]. Cellular Physiology & Biochemistry International Journal of Experimental Cellular Physiology Biochemistry & Pharmacology,2017,41(4):1360−1369.
[16]	王补青. 生活方式及营养状况对老年骨质疏松患者疼痛的影响[J]. 中国药物与临床,2020,20(4):540−542. [Wang Bu-qing. Influence of lifestyle and nutritional status on pain in elderly patients with osteoporosis[J]. Chinese Remedies & Clinics,2020,20(4):540−542.
[17]	Coin A, Perissinotto E, Enzi G, et al. Predictors of low bone mineral density in the elderly: The role of dietary intake, nutritional status and sarcopenia[J]. European Journal of Clinical Nutrition,2008,62(6):802−809. doi: 10.1038/sj.ejcn.1602779
[18]	Morii H, Shioi A, Inaba M, et al. Significance of albumin in the pathogenesis of osteoporosis: Bone changes in genetically analbuminemic rats and rats fed a low al albumin diet[J]. Osteoporosis International,1997,7:30−35. doi: 10.1007/BF03194339
[19]	徐会金. 运动通过 p38MAPK 信号通路对2型糖尿病小鼠骨代谢的影响[D]. 上海: 华东师范大学, 2016. Xu Hu-ijin. The effect of exercise on bone metabolism in type 2 diabetic mellitus mice by p38MAPK signaling pathway[D]. Shanghai: East China Normal University, 2016.
[20]	Senel K, Baykal T, Seferoglu B, et al. Circulating vascular endo the the lial growth factor concentrations in patients with postmenopausal osteoporosis[J]. Arch Med Sci,2013,9:709−712.
[21]	尚国伟. 小鼠骨髓间质干细胞成骨分化及促肾上腺皮质激素的影响[D]. 郑州: 郑州大学, 2014: 1−52. Shang Guo-wei. Osteogenesis of mouse bone marrow mesenchymal stem cells and the impact of adrenocorticotropic hormone[D]. Zhengzhou: Zhengzhou University, 2014: 1−52.
[22]	Hiltunen Mo, Ruuskanen M, Huuskonen J, et al. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo[J]. Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology,2003,17(9):1147−1149. doi: 10.1096/fj.02-0514fje
[23]	徐西林, 张晓峰, 吕航, 等. 补肾/活血法对兔液氮冷冻法股骨头缺血性坏死caspase-3表达的影响[J]. 中医药学报,2017,45(5):36−39. [Xu Xi-lin, Zhang Xiao-feng, Lv Hang, et al. Effect of tonifying kidney and activating blood circulation on caspase-3 expression in rabbits with avascular necrosis of femoral head by liquid nitrogen freezing[J]. Acta Chinese Medicine and Pharmacology,2017,45(5):36−39. doi: 10.3969/j.issn.1002-2392.2017.05.009
[24]	严红梅, 张振海, 孙娥, 等. 中药治疗骨质疏松症的研究进展[J]. 中草药,2014,45(8):1174−1178. [Yan Hong-mei, Zhang Zhen-hai, Sun E, et al. Research progress on treatment of osteoporosis using Chinese materia medica[J]. Chinese Traditional and Herbal Drugs,2014,45(8):1174−1178.
[25]	Jia H R, Ma X Y, Tong W, et al. EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation[J]. Proceedings of the National Academy of Sciences of the United States of America,2016,113(50):14360−14365. doi: 10.1073/pnas.1608938113
[26]	Chandra A, Lan S H, Zhu J, et al. Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expression[J]. Journal of Biological Chemistry,2013,288(28):20488−20498. doi: 10.1074/jbc.M112.447250
[27]	陈亚辉, 龚忠勤, 崔燎. PI3K/Akt信号通路在骨质疏松病理过程中的作用[J]. 中国骨质疏松杂志,2015,21(3):356−360. [Chen Ya-hui, Gong Zhong-qin, Cui Liao. Effect of PI3K/Akt pathway on the pathological development of osteoporosis[J]. Chinese Journal of Osteoporosis,2015,21(3):356−360. doi: 10.3969/j.issn.1006-7108.2015.03.022
[28]	Adapala N S, Barbe M F, Tsygankov A Y, et al. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-R as mediated PI3K activation independent of Cbl-b[J]. J Cell Biochem,2014,115(7):1277−1289.
[29]	Nakchbandi I A. Osteoporosis and fractures in liver disease: Relevance, patho genesis and therapeutic implications[J]. World J Gastroenterol,2014,20(28):9427−9438.
[30]	Wijarnpreecha K, Thongprayoon C, Panjawatanan P, et al. Hepatitis C virus infection and risk of osteoporosis: A meta-analysis[J]. Gastroenterology,2017, 23:216−221.
[31]	刘攀, 姜睿. 前列腺癌骨病诊断和治疗的进展[J]. 临床泌尿外科杂志,2016,31(8):762−766. [Liu Pan, Jiang Rui. Progress in diagnosis and treatment of prostate cancer related bone disease[J]. Journal of Clinical Urology,2016,31(8):762−766.
[32]	Hofbauer L C, Rachner T D, Coleman R E, et al. Endocrine asoects of bone metastases[J]. Lancet Diabetes Endocrinol,2014,2(6):500−502. doi: 10.1016/S2213-8587(13)70203-1
[33]	Reynaert N L, Gopal P, Rutten E P A, et al. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; overview of clinical evidence and potential contributions to diseas[J]. Int J Biochem Cell Biol,2016,81(Pt B):403−418.
[34]	Li G, Xu J, Li Z. Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling[J]. Biochemical and Biophysical Research Communications, 2012, 423(4): 684−689.
[35]	雷晓青, 陈鳌, 刘毅, 等. 山萘酚药理作用的研究进展[J]. 微量元素与健康研究,2017,34(2):61−62. [Lei Xiao-qing, Chen Ao, Liu Yi, et al. Research progress on pharmacological effects of kaempferol[J]. Studies of Trace Elements and Health,2017,34(2):61−62.
[36]	杨颖, 王芸芸, 蒋琦辰. 槲皮素药理作用的研究进展[J]. 特种经济动植物,2020,23(5):24−28. [Yang Ying, Wang Yun-yun, Jiang Qi-chen. Research progress on pharmacological action of quercetin[J]. Special Economic Animals and Plants,2020,23(5):24−28. doi: 10.3969/j.issn.1001-4713.2020.05.009
[37]	Awad A B, Chinnam M, Fink C S, et al. β-Sitosterol activates fas signaling in human breast cancer cells[J]. Phytomedicine,2007,14(11):747−754. doi: 10.1016/j.phymed.2007.01.003
[38]	Alappat L, Valerio M, Awad A B. Effect of vitamin D and β-sitosterol on immune function of macrophages[J]. International Immunopharmacology,2010,10(11):1390−1396. doi: 10.1016/j.intimp.2010.08.003

Supplements (0)

Cited By

Cited by

Periodical cited type(2)

1.	穆雪萌，杜芯仪，王彦超，金云峰，张嘉. 桑椹来源的寡核苷酸显著改善小鼠骨质疏松症. 动物营养学报. 2024(01): 602-609 .
2.	柯昌虎，严慧，赵阳，朱军，李志浩. 基于网络药理学和分子对接探讨黄精抗衰老的作用机制. 湖北农业科学. 2023(10): 100-108+131 .